MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹477 Cr | ₹390 Cr | ₹341 Cr | ₹380 Cr | ₹299 Cr |
What is the latest Total Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹477 Cr |
| Mar2024 | ₹390 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹380 Cr |
| Mar2021 | ₹299 Cr |
How is Total Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹477 Cr | 22.44 | |
| Mar2024 | ₹390 Cr | 14.33 | |
| Mar2023 | ₹341 Cr | -10.29 | |
| Mar2022 | ₹380 Cr | 27.13 | |
| Mar2021 | ₹299 Cr | - | |
Compare Total Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,830.8 Cr | -2.9% | 12% | -0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.9% |
12% |
-0.9% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses